Cargando…

Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy

BACKGROUND: There are no accepted universal biomarkers capable to accurately predict response to immuno-checkpoint inhibitors (ICI). Although recent literature has been flooded with studies on ICI predictive biomarkers, available data show that currently approved companion diagnostics either leave o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pallocca, Matteo, Angeli, Davide, Palombo, Fabio, Sperati, Francesca, Milella, Michele, Goeman, Frauke, De Nicola, Francesca, Fanciulli, Maurizio, Nisticò, Paola, Quintarelli, Concetta, Ciliberto, Gennaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480695/ https://www.ncbi.nlm.nih.gov/pubmed/31014354 http://dx.doi.org/10.1186/s12967-019-1865-8

Ejemplares similares

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
por: Aurisicchio, Luigi, et al.
Publicado: (2019)

Molecular dissection of a hyper-aggressive CBFB-MYH11/FLT3-ITD–positive acute myeloid leukemia
por: Lo Iudice, Gabriele, et al.
Publicado: (2022)

Reverse Engineering Cancer: Inferring Transcriptional Gene Signatures from Copy Number Aberrations with ICAro
por: Angeli, Davide, et al.
Publicado: (2019)

The perfect personalized cancer therapy: cancer vaccines against neoantigens
por: Aurisicchio, Luigi, et al.
Publicado: (2018)

Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer
por: De Nicola, Francesca, et al.
Publicado: (2018)

Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer
por: Pallocca, Matteo, et al.
Publicado: (2018)

Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern tracking
por: Donzelli, Sara, et al.
Publicado: (2022)

Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells
por: Catena, Valeria, et al.
Publicado: (2016)

Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients
por: Palermo, Belinda, et al.
Publicado: (2018)

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
por: Melucci, Elisa, et al.
Publicado: (2018)

Mesenchymal traits at the convergence of tumor-intrinsic and -extrinsic mechanisms of resistance to immune checkpoint blockers
por: Trono, Paola, et al.
Publicado: (2017)

Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes
por: Mazzotta, Marco, et al.
Publicado: (2020)

The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach
por: Villani, Veronica, et al.
Publicado: (2023)

Che-1 sustains hypoxic response of colorectal cancer cells by affecting Hif-1α stabilization
por: Bruno, Tiziana, et al.
Publicado: (2017)

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects
por: Mori, Federica, et al.
Publicado: (2016)

Multicohort and cross‐platform validation of a prognostic Wnt signature in colorectal cancer
por: Goeman, Frauke, et al.
Publicado: (2020)

PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
por: Bazzichetto, Chiara, et al.
Publicado: (2019)

Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants
por: Massacci, Alice, et al.
Publicado: (2020)

Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration
por: Krasniqi, Eriseld, et al.
Publicado: (2022)

Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51
por: Manic, Gwenola, et al.
Publicado: (2021)

Deptor: not only a mTOR inhibitor
por: Catena, Valeria, et al.
Publicado: (2017)

B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells
por: De Vitis, Claudia, et al.
Publicado: (2019)

Machine learning endometrial cancer risk prediction model: integrating guidelines of European Society for Medical Oncology with the tumor immune framework
por: Bruno, Valentina, et al.
Publicado: (2023)

Quality of life and emotional distress in sarcoma patients diagnosed during COVID-19 pandemic: a supplementary analysis from the SarCorD study
por: Onesti, Concetta Elisa, et al.
Publicado: (2023)

The impact of the COVID-19 pandemic on diagnosis and treatment of patients with soft tissue and bone sarcomas or aggressive benign musculoskeletal diseases: A single-center retrospective study (SarCorD study)
por: Onesti, Concetta Elisa, et al.
Publicado: (2022)

MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab
por: Bifulco, Carlo, et al.
Publicado: (2014)

hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC
por: Trono, Paola, et al.
Publicado: (2023)

The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world
por: Giacomini, Patrizio, et al.
Publicado: (2023)

UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response
por: Signore, Michele, et al.
Publicado: (2016)

Micromanaging checkpoint proteins
por: Ciliberto, Andrea, et al.
Publicado: (2017)

Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance
por: Weng, Chao-Yuan, et al.
Publicado: (2021)

Establishment and validation of nomogram for predicting immuno checkpoint inhibitor related pneumonia
por: Li, Xiaoqi, et al.
Publicado: (2022)

Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer
por: Revythis, Antonios, et al.
Publicado: (2022)

The application basis of immuno-checkpoint inhibitors combined with chemotherapy in cancer treatment
por: Shi, Ming-Yan, et al.
Publicado: (2023)

Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients
por: Sacconi, Andrea, et al.
Publicado: (2021)

DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy
por: Noessner, Elfriede
Publicado: (2017)

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights
por: Noelle, Randolph J., et al.
Publicado: (2023)

Are Genetic Vaccines the Right Weapon against COVID-19?
por: Conforti, Antonella, et al.
Publicado: (2020)

Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients
por: Bruschini, Sara, et al.
Publicado: (2022)

A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions
por: Donzelli, Sara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1fd7tv2ho18tcim8jdsgkikobb